Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells

FEBS Letters

Volumn 588, Issue 21, 2014, Pages 3870-3877

  Röhrborn, Diana ^a   Eckel, Jürgen ^a   Sell, Henrike ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

CD26 DPP4; Hypoxia; Non classical secretion; Protease

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; METALLOPROTEINASE; BREFELDIN A; MATRIX METALLOPROTEINASE; PROTEINASE INHIBITOR;

ADIPOCYTE; ARTICLE; CELL HYPOXIA; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; MALE; METABOLISM; SECRETION (PROCESS); SOLUBILITY; UPREGULATION;

ADIPOCYTES; BREFELDIN A; CELL HYPOXIA; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MYOCYTES, SMOOTH MUSCLE; PROTEASE INHIBITORS; SOLUBILITY; UP-REGULATION;

EID: 84908242278     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.08.029     Document Type: Article

References (43)

1. A.M. Lambeir, C. Durinx, S. Scharpe, and I. DeMeester Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit. Rev. Clin. Lab. Sci. 40 2003 209 294
2. K. Kazafeos Incretin effect: GLP-1, GIP, DPP4 Diabetes Res. Clin. Pract. 93 Suppl. 1 2011 S32 S36
3. P. Aschner, M.S. Kipnes, J.K. Lunceford, M. Sanchez, C. Mickel, and D.E. Williams-Herman Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes Diabetes Care 29 2006 2632 2637
4. O.J. Cordero, F.J. Salgado, and M. Nogueira On the origin of serum CD26 and its altered concentration in cancer patients Cancer Immunol. Immunother. 58 2009 1723 1747
5. D. Lamers, S. Famulla, N. Wronkowitz, S. Hartwig, S. Lehr, D.M. Ouwens, K. Eckardt, J.M. Kaufman, M. Ryden, S. Müller, F.-G. Hanisch, J. Ruige, P. Arner, H. Sell, and J. Eckel Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome Diabetes 60 2011 1917 1925
6. S. Lehr, S. Hartwig, D. Lamers, S. Famulla, S. Muller, F.G. Hanisch, C. Cuvelier, J. Ruige, K. Eckardt, D.M. Ouwens, H. Sell, and J. Eckel Identification and validation of novel adipokines released from primary human adipocytes Mol. Cell. Proteom. 11 2012 M111
7. N.M. Hooper, E.H. Karran, and A.J. Turner Membrane protein secretases Biochem. J. 321 Pt. 2 1997 265 279
8. D. Dietze-Schroeder, H. Sell, M. Uhlig, M. Koenen, and J. Eckel Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors Diabetes 54 2005 2003 2011
9. T. Skurk, S. Ecklebe, and H. Hauner A novel technique to propagate primary human preadipocytes without loss of differentiation capacity Obesity (Silver Spring) 15 2007 2925 2931
10. S. Raschke, K. Eckardt, H.K. Bjorklund, J. Jensen, and J. Eckel Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells PLoS One 8 2013 e62008
11. C. Chavey, B. Mari, M.N. Monthouel, S. Bonnafous, P. Anglard, O.E. Van, and S. Tartare-Deckert Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation J. Biol. Chem. 278 2003 11888 11896
12. E. Maquoi, C. Munaut, A. Colige, D. Collen, and H.R. Lijnen Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity Diabetes 51 2002 1093 1101
13. W. Nickel The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes Eur. J. Biochem. 270 2003 2109 2119
14. D. Caccia, M. Dugo, M. Callari, and I. Bongarzone Bioinformatics tools for secretome analysis Biochim. Biophys. Acta 1834 11 2013 2442 2453
15. H. Lodish, A. Berk, and S.L. Zipursky Molecular Cell Biology. Insertion of Membrane Proteins into the ER Membrane fourth ed. 2000 W. H. Freeman New York
16. S. Chakraborti, M. Mandal, S. Das, A. Mandal, and T. Chakraborti Regulation of matrix metalloproteinases: an overview Mol. Cell. Biochem. 253 2003 269 285
17. H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 1994 61 65
18. M. Toth, I. Chvyrkova, M.M. Bernardo, S. Hernandez-Barrantes, and R. Fridman Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes Biochem. Biophys. Res. Commun. 308 2003 386 395
19. W.B. Saunders, K.J. Bayless, and G.E. Davis MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices J. Cell Sci. 118 2005 2325 2340
20. X. Lu, Q. Wang, G. Hu, P.C. Van, M. Fleisher, M. Reiss, J. Massague, and Y. Kang ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis Genes Dev. 23 2009 1882 1894
21. S. Reinboldt, F. Wenzel, B.H. Rauch, T. Hohlfeld, M. Grandoch, J.W. Fischer, and A.A. Weber Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets Platelets 20 2009 441 444
22. A.S. Ribeiro, A. Albergaria, B. Sousa, A.L. Correia, M. Bracke, R. Seruca, F.C. Schmitt, and J. Paredes Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells Oncogene 29 2010 392 402
23. E. Fiore, C. Fusco, P. Romero, and I. Stamenkovic Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity Oncogene 21 2002 5213 5223
24. A.L. Sabbota, H.R. Kim, X. Zhe, R. Fridman, R.D. Bonfil, and M.L. Cher Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration Cancer Res. 70 2010 5558 5566
25. G. Preece, G. Murphy, and A. Ager Metalloproteinase-mediated regulation of l-selectin levels on leucocytes J. Biol. Chem. 271 1996 11634 11640
26. M.R. Alexander, C.W. Moehle, J.L. Johnson, Z. Yang, J.K. Lee, C.L. Jackson, and G.K. Owens Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice J. Clin. Invest. 122 2012 70 79
27. L.M. Hulten, and M. Levin The role of hypoxia in atherosclerosis Curr. Opin. Lipidol. 20 2009 409 414
28. D.V. Faller Endothelial cell responses to hypoxic stress Clin. Exp. Pharmacol. Physiol. 26 1999 74 84
29. K. Nakayama CAMP-response element-binding protein (CREB) and NF-kappaB transcription factors are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1 J. Biol. Chem. 288 2013 22584 22595
30. Y. Yamamoto, T. Osanai, F. Nishizaki, T. Sukekawa, K. Izumiyama, S. Sagara, and K. Okumura Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-alpha Heart Vessels 27 2012 624 633
31. P. Saftig, and K. Reiss The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90 2011 527 535
32. H. Sell, M. Bluher, N. Kloting, R. Schlich, M. Willems, F. Ruppe, W.T. Knoefel, A. Dietrich, B.A. Fielding, P. Arner, K.N. Frayn, and J. Eckel Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro Diabetes Care 36 12 2013 4083 4090
33. G. Derosa, I. Ferrari, A. D'Angelo, C. Tinelli, S.A. Salvadeo, L. Ciccarelli, M.N. Piccinni, A. Gravina, F. Ramondetti, P. Maffioli, and A.F. Cicero Matrix metalloproteinase-2 and -9 levels in obese patients Endothelium 15 4 2008 219 224
34. Y.J. Lee, Y.S. Heo, H.S. Park, S.H. Lee, S.K. Lee, and Y.J. Jang Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults Obes. Surg. 24 4 2014 604 610
35. A. Muller, S.D. Kramer, R. Meletta, K. Beck, S.V. Selivanova, Z. Rancic, P.A. Kaufmann, B. Vos, J. Meding, T. Stellfeld, T.K. Heinrich, M. Bauser, J. Hutter, L.M. Dinkelborg, R. Schibli, and S.M. Ametamey Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability Nucl. Med. Biol. 41 7 2014 562 569
36. C. Tan, Y. Liu, W. Li, F. Deng, X. Liu, X. Wang, Y. Gui, L. Qin, C. Hu, and L. Chen Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness Atherosclerosis 232 1 2014 199 203
37. D. Silvello, L.B. Narvaes, L.C. Albuquerque, L.F. Forgiarini, L. Meurer, N.C. Martinelli, M.E. Andrades, N. Clausell, K.G. dos Santos, and L.E. Rohde Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability Biomarkers 19 1 2014 49 55
38. M. Lehrke, M. Greif, U.C. Broedl, C. Lebherz, R.P. Laubender, A. Becker, Z.F. von, J. Tittus, M. Reiser, C. Becker, B. Goke, G. Steinbeck, A.W. Leber, and K.G. Parhofer MMP-1 serum levels predict coronary atherosclerosis in humans Cardiovasc. Diabetol. 8 2009 50 58
39. T.P. Zheng, F. Yang, Y. Gao, A. Baskota, T. Chen, H.M. Tian, and X.W. Ran Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: a prospective study Atherosclerosis 235 2 2014 619 624
40. N. Wronkowitz, L.A. Villalobos, C.F. Sanchez-Ferrer, C. Peiro, H. Sell, and J. Eckel Dipeptidyl peptidase 4 (DPP4) induces inflammation and proliferation of human smooth muscle cells by activation of the ERK-signalling pathway Diabetes 62 Suppl. 1 2013 A52
41. N. Ervinna, T. Mita, E. Yasunari, K. Azuma, R. Tanaka, S. Fujimura, D. Sukmawati, T. Nomiyama, A. Kanazawa, R. Kawamori, Y. Fujitani, and H. Watada Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice Endocrinology 154 2013 1260 1270
42. L. Pala, and C.M. Rotella The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence J. Diabetes Res. 2013 2013 590456
43. G.P. Fadini, and A. Avogaro Cardiovascular effects of DPP-4 inhibition: beyond GLP-1 Vascul. Pharmacol. 55 1-3 2011 10 16